Reprogenetics: CooperSurgical pays $47m for IVF screener Reprogenetics

Cooper Cos. (NYSE:COO) CooperSurgical subsidiary acquired in-vitro fertilization screening company Reprogenetics last week for nearly $47 million. Livingston, N.J.-based Reprogenetics offers pre-implantation genetic screening and diagnosis for in vitro fertilization, Cooper said. The $46.5 million deal isn't expected to affect earnings per share this year or in 2016, but should be accretive thereafter, the company said. Reprogenetics put up [...]The post CooperSurgical pays $47m for IVF screener Reprogenetics appeared first on MassDevice.